...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF

Resent this am,,,simple fair question imo and not looking for info that is material and might fall under certain disclsure rules,,just a basic question is all!!!

 

 

info@zenithepigenetics.com'

Hello Investor Relations,

                Hope all is good with Zenith,,,,,,,Will there be some data released from the trials we are collaborating on with these Pharmas in 2024? I see we expect to complete 7 of the initial Pl and Pll trials in H1, with 4 more by year end.

Thanks for any info offered.

Share
New Message
Please login to post a reply